Three cases of relapsing orbital myositis that responded well to steroid therapy, but recurred during steroid tapering, were identified. The recurrence was associated with severe pain in different extraocular muscles and the contralateral eye.
Case 1 was 62-year-old male patient. He had 5 recurrent episodes of orbital myositis that had responded well to steroid therapy; however, immunosuppression, including methotrexate (MTX) and oral prednisolone (PSL), was required for reducing the recurrence rate. Case 2 was 29-year-old male patient. He received radiation therapy after the third recurrence. Subsequently, he visited another hospital and was treated with PSL and MTX, but relapsed. He had a total of 5 episodes of recurrence; local injection of triamcinolone acetonide (TA), in addition to PSL and MTX, effectively reduced the frequency of relapse for over 3 years after the last recurrence. Case 3 was 41-year-old female patient. Her first visit to our department was with her sixth recurrence of orbital myositis. She was started on steroid pulse therapy, but inflammation of her right orbit recurred during pulse therapy. Subsequently, MTX and PSL were prescribed. She experienced steroid glaucoma when the PSL dose was increased from 25 mg to 40 mg. Despite the use of glaucoma drops, she developed uncontrollably high intraocular pressure and a trabeculotomy was performed. Since her trabeculotomy, PSL and MTX have prevented disease recurrence.
The outcomes of these cases suggest that treatment of relapsing migratory orbital myositis requires immunosuppression, including local injection of TA and oral PSL, given at an earlier stage of the disease.
View full abstract